Elena Marquez Sells 4,981 Anterix (ATEX) Shares at $81.90 Each, Totalling $400,606
On October 13, 2026, Elena Marquez, Anterix Inc.'s Chief Financial Officer, sold 4,981 shares at $81.90 each, totaling $400,606, as per the SEC's Form 4.
Elena Marquez, Chief Financial Officer of Anterix Inc., sold 4,981 shares of the company on October 13, 2026, at a price of $81.90 per share, amounting to a total transaction value of $400,606.
Who is Elena Marquez and What is Her Real Role at Anterix?
Elena Marquez serves as the Chief Financial Officer (CFO) at Anterix Inc., a publicly traded company under the ticker symbol ATEX. In this role, she oversees the company's financial management, including accounting, financial reporting, treasury functions, budgeting, and investor relations. As a CFO, she has direct access to strategic information, earnings forecasts, and financing plans that have not yet been made public.
The CFO also participates in decisions regarding acquisitions, stock or bond issuance, and risk management strategies. This position places her among the most informed executives about the company's short- and medium-term prospects, which is why there is a legal requirement to disclose any transactions involving the company's securities through the SEC's Form 4 filing.
Transaction Details: 4,981 Shares at $81.90 Each
The SEC Form 4 indicates that the transaction took place on October 13, 2026. Elena Marquez sold 4,981 Anterix Inc. shares at a per-unit price of $81.90. The total value of the sale amounts to $400,606. It is important not to confuse the per-share price ($81.90) with the total transaction value ($400,606), two distinct figures provided in the official filing.
The number of shares sold represents a portion of the executive's holdings, but the filing does not specify the exact proportion relative to her total ownership. The transaction was reported as required by regulations, which mandate that officers and directors of publicly traded companies file a Form 4 within two business days of the transaction.
Why Insiders Sell Their Shares â Possible Reasons
Share sales by executives can be motivated by various reasons that do not necessarily reflect their opinion on the stock's future value. Common motives include diversifying personal assets, generating liquidity for private expenses (such as purchasing real estate or funding education), or optimizing tax obligations through capital gains planning. A CFO might also sell to rebalance their investment portfolio, reduce exposure to a single security, or meet internal compliance requirements.
It is important to note that the decision to sell may be independent of the expected company performance. Additionally, the "insider sell" signal mentioned in the data should not be interpreted as a prediction of the stock's direction but simply as the classification of the transaction based on the fact that it is a sale.
How Individual Investors Track Form 4 Filings
Individual investors can access Form 4 filings through the SEC's official website, EDGAR (Electronic Data Gathering, Analysis, and Retrieval system). The filing is generally available free of charge in HTML or PDF format and includes details of each insider transaction, such as the insider's name, title, number of shares, price, and date.
Online tools, such as financial data aggregators (Finviz, WhaleWisdom, or brokerage platforms offering regulatory information feeds), allow filtering transactions by company, insider type (officer, director, employee), or amount. However, the information contained in Form 4 filings is limited to the transaction itself and does not provide insight into underlying motivations or company strategies.
Investors should consider these data points as one element among many in their analysis process, combining them with quarterly reports, press releases, and macroeconomic indicators to form a more comprehensive view of the stock.
In summary, Elena Marquez's Form 4 filing shows the sale of 4,981 Anterix shares at $81.90 each, totaling $400,606, reported on the same day as required by SEC regulations. The CFO of a publicly traded company possesses privileged information, but the reasons for a sale can be multiple and should not be interpreted as definitive market signals. Individual investors have free tools to monitor these filings, but they should analyze them prudently within the broader context of the company.
